Close

FBR Capital Reiterates Outperform on Evoke Pharma (EVOK) Following 2Q Report

Go back to FBR Capital Reiterates Outperform on Evoke Pharma (EVOK) Following 2Q Report
EVOKE PHARMA (NASDAQ: EVOK) Delayed: 0.50 +0.02 (4.17%)
Previous Close $0.48    52 Week High $11.11 
Open $0.50    52 Week Low $1.35 
Day High $0.50    P/E N/A 
Day Low $0.50    EPS $-0.57 
Volume 759